Synopsys
$434.94Change from previous close: +4.78%Absolute change: +$19.85
At a glance
- Revenue growth
- +15.12%
- FY to Oct 2025 vs FY to Oct 2024
- Net income growth
- −41.14%
- FY to Oct 2025 vs FY to Oct 2024
- Net margin
- 18.9%
- FY to Oct 2024: 36.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Oct 2025 | FY to Oct 2024 | FY to Oct 2023 | FY to Oct 2022 | FY to Oct 2021 |
|---|---|---|---|---|---|
| Total revenue | 7,054 | 6,127 | 5,318 | 4,616 | 4,204 |
| Cost of revenue | 1,312 | 1,137 | 986 | 853 | 813 |
| Gross profit | 5,742 | 4,990 | 4,332 | 3,762 | 3,391 |
| Selling, general and administrative | 1,844 | 1,428 | 1,102 | 956 | 1,035 |
| Research and development | 2,479 | 2,082 | 1,850 | 1,590 | 1,505 |
| Operating income | 915 | 1,409 | 1,326 | 1,160 | 768 |
| EBIT | 915 | 1,409 | 1,326 | 1,160 | 768 |
| EBITDA | 1,328 | 1,599 | 1,526 | 1,343 | 922 |
| Interest expense | 447 | 36.8 | 2.7 | 1.7 | 3.4 |
| Pre-tax income | 1,393 | 1,514 | 1,305 | 1,103 | 806 |
| Income tax | 56.0 | 99.7 | 90.2 | 139 | 49.2 |
| Net income | 1,332 | 2,263 | 1,230 | 985 | 758 |
| Net income to common shareholders | 1,332 | 2,263 | 1,230 | 985 | 758 |
| Basic EPS | 8.13 | 14.78 | 8.08 | 6.44 | 4.96 |
| Diluted EPS | 8.05 | 14.52 | 7.93 | 6.29 | 4.81 |
| Average shares (basic) | 164 | 153 | 152 | 153 | 153 |
| Average shares (diluted) | 166 | 156 | 155 | 156 | 157 |